Comparative Profile between Cutaneous and Systemic Vasculitis
Farhana Wahab
Kuwait Bangladesh Friendship Government Hospital, Bangladesh.
Lubna Khondker *
Department of Dermatology and Venereology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Bangladesh.
Marzia Zaman Sultana
Department of Social Relations, East west University, Bangladesh.
Farhana Afrooz
Dhaka Medical College Hospital, Dhaka, Bangladesh.
*Author to whom correspondence should be addressed.
Abstract
Background: Since initial manifestation of systemic vascuitis commonly present on skin, dermatologists have an important role to investigate whether vasculitis is localized or systemic. Recognition of localized cutaneous versus systemic vasculitis is important in terms of making the correct diagnosis, evaluation of disease activity, prescribing treatment and arranging appropriate clinical follow-up.
Methods and Materials: This was a cross sectional type of observational study which was conducted from July, 2016 to December, 2017. Study population was the individuals diagnosed as primary cutaneous vasculitis or systemic vasculitis. Consecutive sampling method was applied. About 32 patients of primary cutaneous vasculitis and 16 patients of systemic vasculitis were taken as study subjects attending at Department of Dermatology & Venereology and Vasculitis clinic of Rheumatology Department, Bangabandhu Sheikh Mujib Medical University (BSMMU) during the time period as per selection criteria.
Results: The mean age of systemic vasculitis group and cutaneous vasculitis group were 36.75±13.67 and 25.16±9.47 months respectively which set significant difference by unpaired t test (p<0.001). Children (≤18 years) were commonly affected by cutaneous vasculitis (34.4%) than systemic vasculitis (12.5%). Males were mostly (68.8%) affected by systemic vasculitis and females (59.4%) were mostly affected by cutaneous vasculitis. Leukocytoclastic vasculitis (LCV) was the commonest presentation of cutaneous vasculitis (62.5%) and Polyarteritis nodosa (PAN) was the commonest presentation of systemic vasculitis (43.8%). Mean RDW, disease duration, WBC, RBC, CRP, Hb% show significant difference between the two groups and most of the patients (87.5%) in systemic vasculitis group had higher disease activity score (more severe).
Conclusion: Leukocytoclastic vasculitis (LCV) was the commonest presentation of cutaneous vasculitis and Polyarteritis nodosa (PAN) was the commonest presentation of systemic vasculitis and most of the patients in systemic vasculitis group had higher disease activity score (more severe).
Keywords: Cutaneous vasculitis, systemic vasculitis, leukocytoclastic vasculitis (LCV), polyarteritis nodosa (PAN)
How to Cite
Downloads
References
Reinhold‐Keller E, Herlyn K, Wagner‐Bastmeyer R and Gross, WL. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Care & Research. 2005;53(1):93-99.
Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. American Journal of Clinical Dermatology. 2008;9(2):71-92.
Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. The American Journal of Dermatopathology. 2005;27(6):504-528.
Pina T, Blanco R and González-Gay MA. Cutaneous vasculitis: a rheumatologist perspective. Current Allergy and Asthma Reports. 2013;13(5):545-554.
Sneller MC and Fauci AS. Pathogenesis of vasculitis syndromes. Medical Clinics 1997; 81(1):221-242.
Danila MI and Bridges SL. Update on pathogenic mechanisms of systemic necrotizing vasculitis. Current rheumatology reports 2008; 10(6):430- 435.
Marzano AV, Vezzoli P and Berti E. Skin involvement in cutaneous and systemic vasculitis. Autoimmunity reviews 2013; 12(4):467-476.
Goeser MR, Laniosz V and Wetter DA. A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis. American journal of clinical dermatology 2014; 15(4):299- 306.
Kim DS, Shin D, Kim TG, Kim SH, Kim SM and Lee MG. Red blood cell distribution width as a useful indicator to predict systemic vasculitis in patients with cutaneous vasculitis. Journal of Dermatology2014; 41:64.
Carlson JA. Resolving Quandaries in Dermatology, Pathology, and Dermatopathology. The American Journal of Dermatopathology 2001; 23(6):555-556
Yoo J, Kim HJ, Jung SM, Song JJ, Park YB and Lee SW. Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis. Yonsei medical journal2018; 59(2):294-302.
Biscetti F, Carbonella A, Parisi F, Bosello SL, Schiavon F, Padoan R et al. 2016. The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU). Medicine 2016; 95(48): 56-59
Kiran BR, Naik MP and Kumar BP. Clinico-Patho-Etiological Study of Cutaneous Vasculitis. IOSR Journal of Dental and Medical Science 2017; 16(7):20-26
Asaduzzaman ATM, Chowdhury MMH, Jaigirdar MQH, Mahmud MM, Choudhury AM and Paul HK. 2016. Clinicopathological study of cutaneous vasculitides. Journal of Pakistan Association of Dermatology2016; 24(1):8-14.
Watts RA and Scott DG. Epidemiology of the vasculitides. Current opinion in rheumatology2003; 15(1):11-16.
Mahr A, Guillevin L, Poissonnet M and Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg‐Strauss syndrome in a French urban multiethnic population in 2000: A capture–recapture estimate. Arthritis Care & Research. 2004;51(1):92-99.